Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention: A Randomized Control Trial

NCT07536802 is registered in ClinicalTrials.gov with National Institute of Cardiovascular Diseases, Pakistan as lead sponsor.

NCT NCT07536802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07536802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention: A Randomized Control Trial
Lead sponsor
National Institute of Cardiovascular Diseases, Pakistan
Phase
Phase 4
Overall status
Recruiting
Start date
June 1, 2025
Completion date
December 31, 2026
Enrollment
1,148 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, coronary slow flow, no-reflow phenomenon, st-segment elevation myocardial infarction (stemi)